Delivery Order SPE2DB20D3303-SPE2DB25FA1SK
- Not listed
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,437.98 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $1,904.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This competitively awarded, non-set-aside contract is scheduled for completion by September 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $15,070.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 10, 2025, with an ultimate completion date of July 11, 2025. This delivery order is a non-set-aside competitive award fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,228.25 delivery order on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,181.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pens on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $16,763.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on November 10, 2025, with a completion date of November 12, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,709.83 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on November 17, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription diabetes medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a ceiling value of $3,434.34. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and represents a non-competitive set-aside transaction. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1SKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,030.39 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units) on July 23, 2025, with a completion date of July 24, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Mounjaro, a diabetes medication, aligns with the company's established portfolio of specialty medications and brand-name pharmaceuticals delivered through the DLA Medical Supply Chain. The delivery order reflects the company's capability to fulfill federal medical supply requirements through open competition and supports the broader strategic objective of ensuring reliable pharmaceutical availability for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/23/25 |